Cardiac Autonomic Dysfunction As a Sign of Irreversible Advanced Heart Failure

ConditionHeart Failure
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital Bispebjerg and Frederiksberg

About this trial

The main hypothesis is that autonomic dysfunction cannot improve among patients reaching end-stage heart failure. To evaluate this, patients admitted with acute decompensated heart failure in Bispebjerg hospital, and history one or more admissions with the same condition within the prior year, will undergo repeated brief heart monitoring (10 min). Baseline recordings (at admission) will be compared with equivalent measurements before discharge to explore whether heart rate variability increases. Patients will be followed for six months after discharge from the hospital.

Eligibility criteria

Qualifiers

18-years age or older

admitted with acute decompensated heart failure for less than 48 h

Disqualifiers

pacemaker

not signed informed consent

other heart rhythm than sinus rhythm or atrial fibrillation

Trial design

Treatments tested in this trial

  • heart monitoring

Treatment groups

No treatment groups listed